Profile | GDS4284 / 223117_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2790.89 | 88 |
GSM687648 | Patient 402 control | 1851.67 | 83 |
GSM687653 | Patient 403 control | 1856.53 | 83 |
GSM687658 | Patient 404 control | 1957.12 | 83 |
GSM687663 | Patient 411 control | 1510.56 | 80 |
GSM687668 | Patient 422 control | 1676.96 | 81 |
GSM687673 | Patient 424 control | 1601.36 | 81 |
GSM687678 | Patient 425 control | 2056.96 | 84 |
GSM687683 | Patient 427 control | 1684.49 | 81 |
GSM687688 | Patient 428 control | 1543.52 | 80 |
GSM687695 | Patient 441 control | 1282.44 | 79 |
GSM687699 | Patient 443 control | 1420.18 | 79 |
GSM687704 | Patient 444 control | 1910.6 | 83 |
GSM687707 | Patient 448 control | 2261.84 | 86 |
GSM687712 | Patient 449 control | 2250.92 | 85 |
GSM687719 | Patient 450 control | 2023.3 | 84 |
GSM687724 | Patient 451 control | 2324.12 | 86 |
GSM687728 | Patient 452 control | 1833.89 | 83 |
GSM687646 | Patient 401 treated 24h | 2200.93 | 85 |
GSM687649 | Patient 402 treated 24h | 1930.95 | 83 |
GSM687665 | Patient 411 treated 24h | 1446.75 | 79 |
GSM687651 | Patient 402 treated 4 weeks | 1436.47 | 79 |
GSM687667 | Patient 411 treated 4 weeks | 1821.12 | 82 |
GSM687670 | Patient 422 treated 24h | 1973.91 | 84 |
GSM687671 | Patient 422 treated 4 weeks | 1838.51 | 82 |
GSM687654 | Patient 403 treated 24h | 1786.2 | 82 |
GSM687675 | Patient 424 treated 24h | 1804.77 | 83 |
GSM687685 | Patient 427 treated 24h | 1386.75 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 1808.34 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 1406.51 | 79 |
GSM687687 | Patient 427 treated 4 weeks | 2066.96 | 84 |
GSM687692 | Patient 428 treated 4h | 2346.28 | 86 |
GSM687716 | Patient 449 treated 4h | 2272.15 | 85 |
GSM687722 | Patient 450 treated 4h | 1811.65 | 83 |
GSM687680 | Patient 425 treated 24h | 1895.46 | 83 |
GSM687690 | Patient 428 treated 24h | 2147.08 | 85 |
GSM687700 | Patient 443 treated 24h | 1223.38 | 77 |
GSM687705 | Patient 444 treated 24h | 2061.75 | 84 |
GSM687714 | Patient 449 treated 24h | 2364.9 | 86 |
GSM687721 | Patient 450 treated 24h | 1747.92 | 82 |
GSM687682 | Patient 425 treated 4 weeks | 1677.58 | 81 |
GSM687694 | Patient 428 treated 4 weeks | 1932.45 | 83 |
GSM687702 | Patient 443 treated 4 weeks | 1705.27 | 82 |
GSM687718 | Patient 449 treated 4 weeks | 2322.18 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 1843.74 | 83 |
GSM687661 | Patient 404 treated 4h | 2191.93 | 85 |
GSM687710 | Patient 448 treated 4h | 2186.07 | 85 |
GSM687726 | Patient 451 treated 4h | 2017.17 | 84 |
GSM687730 | Patient 452 treated 4h | 2229.52 | 87 |
GSM687660 | Patient 404 treated 24h | 1728.02 | 84 |
GSM687697 | Patient 441 treated 24h | 1074.31 | 76 |
GSM687709 | Patient 448 treated 24h | 2171.72 | 85 |
GSM687725 | Patient 451 treated 24h | 1655.69 | 82 |
GSM687729 | Patient 452 treated 24h | 1450.26 | 81 |
GSM687727 | Patient 451 treated 4 weeks | 1564.4 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 1462 | 80 |